Re: Sudden hearing loss.
Ifeacho
S
S
Narula
A
A
D000212:Acyclovir / Q000009:adverse effects* / Q000031:analogs & derivatives*; D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000009:adverse effects*; D001682:Biological Availability; D003907:Dexamethasone / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D006319:Hearing Loss, Sensorineural / Q000139:chemically induced / Q000188:drug therapy / Q000503:physiopathology; D003639:Hearing Loss, Sudden / Q000139:chemically induced / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D008775:Methylprednisolone / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D014432:Tympanic Membrane / Q000187:drug effects; D000077483:Valacyclovir; D014633:Valine / Q000009:adverse effects / Q000031:analogs & derivatives*
D000893:Anti-Inflammatory Agents; D000998:Antiviral Agents; D003907:Dexamethasone; D014633:Valine; D000077483:Valacyclovir; D000212:Acyclovir; D008775:Methylprednisolone